Back

American Association for the Study of Liver Diseases

  • Anticoagulants
  • Hypertension, Portal
  • Liver Cirrhosis
  • Thrombosis

Anticoagulation in portal vein thrombosis among patients with cirrhosis; myths vs evidence (ondemand)

Management of portal vein thrombosis in portal hypertension, including selection of the optimal candidates, specific anticoagulant and duration of anticoagulation are important topics that are encountered in daily practice. However, these decisions are not straight forward and need to take into account several aspects of each case, including transplant candidacy, severity of liver disease and extend of the portal vein thrombosis. Additionally, patients with cirrhosis are at increased risk of bleeding events, and risks and benefits of anticoagulation need to be individually assessed in each patient. This webinar will address common questions and controversies in the management of such patients. It is intended for hepatologists, gastroenterologists, physician assistants, nurse practitioners, fellows and trainees. Others with an interest in managing patients with portal hypertension and the duration of anticoagulation are invited to attend.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

No specific specialties targeted.

Pricing

Free

Reported to ACCME by the provider

  • Blended / Other
  • Credit · Up to 1 credit
  • Released
    Sep 8, 2026
  • Last day to claim credit
    Sep 9, 2027 11 months left